Artwork
iconShare
 
Manage episode 382631118 series 3526489
Content provided by Ivanna Rosendal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ivanna Rosendal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

How is the pharmaceutical and biotech industry changing in the current financial climate? Our guest today, Ryan Keane, founder and CEO of Korio, shines a bright light on these subjects and more. This discussion is an exploration of our current healthcare landscape, dissecting the challenges companies face as they introduce new technology, the sudden shift in the vendor landscape, and the unexpected destruction of value in biotech due to companies discarding or divesting their assets.
We don't just stop at the surface. Ryan takes us deep into the complexities of customizing Interactive Response Technology (IRT) systems in clinical trials, highlighting the crucial role of education for both buyers and industry employees. We tackle the challenges of communicating complex information to patients and the need for creating reproducible and scalable processes. The conversation veers into the often misunderstood realm of clinical trial supply, the need for a no-code environment, and the importance of having technologically savvy folks who comprehend all the elements.
Guest:
Ryan Keane

Support the show

________
Reach out to Ivanna Rosendal
Join the conversation on our LinkedIn page

  continue reading

Chapters

1. Clinical Trial Supply is like an entire Galaxy with Ryan Keane (00:00:00)

2. The State of Pharma and Biotech (00:00:21)

3. The Challenges of Customizing IRT Systems (00:15:04)

4. Challenges and Integration in Clinical Trials (00:25:23)

85 episodes